TNFSF11 and myeloid sarcoma: Study limitations include the lack of significance of our preselected primary phenotype, the lack of statistical correction employed for the detected association (Table 2), between-study differences in MS-AE collection and definition, potential confounding from analyzing a multiancestry cohort, and the lack of RANKL and OPG expression data in our cohort.